Beryl Drugs Quarterly Results for Trading Insights
BERLDRG • Latest quarterly financial performance to support trade journaling in Tickjournal
Latest Quarter Net Profit
₹1 Cr
QMarch 2025
Beryl Drugs Quarterly Results Key Highlights
- Revenue of ₹23 Cr in March 2025 (+0.0% vs March 2025, -14.8% vs March 2024)
- Net Profit of ₹1 Cr in March 2025 (+0.0% vs March 2025, +0.0% vs March 2024)
- EBITDA of ₹3 Cr in March 2025 (+0.0% vs March 2025)
- Operating Margin of 6.0% in March 2025 (+0.0pp vs March 2025)
- Earnings Per Share of ₹1.14 in March 2025 (+0.0% vs March 2025)
Beryl Drugs Quarterly Results Analysis
| Metric | 2026 | March 2025 | March 2024 | March 2023 | March 2022 | QoQ | YoY |
|---|---|---|---|---|---|---|---|
| Revenue (₹ Cr) | 21 | 23 | 27 | 27 | 15 | -8.7% | - |
| Net Profit (₹ Cr) | 0 | 1 | 1 | 1 | -1 | - | - |
| EBITDA (₹ Cr) | 2 | 3 | 3 | 2 | 1 | - | - |
| EPS (₹) | 0.50 | 1.14 | 1.52 | 1.51 | -1.30 | - | - |
| Operating Margin (%) | 4.0% | 6.0% | 9.0% | 7.0% | 3.0% | - | - |
Beryl Drugs Share Price Trend Around Quarterly Results
Visualize Beryl Drugs's 1-year price movement across quarterly results — ideal for logging trades in Beryl Drugs share price
chart using Tickjournal. All values in ₹.
Related Pages for Beryl Drugs
Additional stock information and data for BERLDRG
Revenue Trend (₹ Cr)
March 2023
27
March 2024
27
March 2025
23
2026
21
Net Profit Trend (₹ Cr)
March 2023
1
March 2024
1
March 2025
1
2026
0
Operating Margin Trend (%)
March 2023
7.0%
March 2024
9.0%
March 2025
6.0%
2026
4.0%
Sector Competitors - Quarterly Performance Comparison
Comparing Beryl Drugs quarterly results with other companies in Healthcare sector
| Company Latest Quarter | Market Cap (₹ Cr) | Price (₹) | Revenue (₹ Cr) | Net Profit (₹ Cr) | Rev QoQ % | Rev YoY % | Profit Margin % | P/E Ratio |
|---|---|---|---|---|---|---|---|---|
|
Sun Pharmaceutical
Sept 2025 |
₹409,758.43 Cr | 1711.1 | 14,875 | 3,125 | +10.8% | - | 21.0% | 131.6 |
|
Divis Laboratories
Sept 2025 |
₹163,940.12 Cr | 6386.5 | 2,860 | 689 | +7.1% | - | 24.1% | 245.9 |
|
Torrent Pharmaceuti…
Sept 2025 |
₹138,072.20 Cr | 4056.7 | 3,219 | 591 | +11.3% | - | 18.4% | 231.3 |
|
Cipla
Sept 2025 |
₹109,041.12 Cr | 1349.9 | 7,716 | 1,353 | +12.0% | - | 17.5% | 80.7 |
|
Dr Reddys Laborator…
Sept 2025 |
₹104,829.57 Cr | 1270.3 | 9,135 | 1,337 | +1.1% | - | 14.6% | 78.5 |
Sector Quarterly Performance Comparison
Healthcare sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data
QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores
All amounts in ₹ Crores